BIOAVENGE

BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of genes and gene expression, and genetic sequences of biological significance into a gene discovery, functional analysis, and identification of bio hazardous agents. It also utilizes its technology for target validation, screening bio hazardous contamination, diagnostic applications, and prophylactic and therapeutic vaccine development. The company was founded in 2000 and is based in Gaithersburg, Maryland. As of February 12, 2008, BioAvenge operates as a subsidiary of GateKeeper USA, Inc. (OTCPK:GTKP).

#More

BIOAVENGE

Industry:
Biotechnology Genetics

Founded:
2000-01-01

Address:
Gaithersburg, Maryland, United States

Country:
United States

Status:
Active


More informations about "BioAvenge"

BioAvenge - Crunchbase Company Profile & Funding

BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of genes and gene expression, and genetic sequences of biological significance into a gene discovery, functional analysis, and โ€ฆSee details»

BioAvenge - Crunchbase

BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study ofSee details»

BioAvenge - Company Profile and News - Bloomberg Markets

Company profile page for BioAvenge including stock price, company news, executives, board members, and contact informationSee details»

GateKeeper USA acquires BioAvenge - 2008-02-06 - Crunchbase

BioAvenge BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of. Acquiring Organization: GateKeeper โ€ฆSee details»

Avenge Bio Announces FDA Clearance of the AVB-001 โ€ฆ

Aug 3, 2022 Avenge Bio expects to initiate a Phase 1 clinical trial in the second half of 2022 for patients with metastatic peritoneal cancers with an initial focus on platinum-resistant ovarian cancerSee details»

Tech Transfer From Client Avenge Bio Results in First โ€ฆ

Newark, New Jersey โ€“ January 17, 2023 โ€“ BioCentriq, Inc.โ€”a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)โ€”announced today that they have successfully โ€ฆSee details»

BioAvenge Company Profile, Financial and Strategic SWOT โ€ฆ

BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of genes and gene expression, and genetic โ€ฆSee details»

BioAvenge+organization - NL Classifieds

Find Bioavenge+organization in Lawn & Garden | Find new & used lawn & garden items for sale. Shop the latest items in lawn and garden including BBQs & grills, generators, snow blowers, โ€ฆSee details»

BioAvenge - biobank.co.kr

BioAvenge subsidiary of GateKeeper USA Inc. 9620 Medical Center Drive. Suite 100. Rockville. MD 20850 USA +1-631-499-3684 +1-631-499-3682: www.gatekeeperusainc.com: โ€ฆSee details»

Avenge Bio - Craft

Avenge Bio is a company developing cell-generated immunotherapies to treat solid tumors. It offers a drug delivery platform that allows users to order cytokines and other โ€ฆSee details»

BIOAVENGE - Dun & Bradstreet

Bioavenge was founded in 2008, and is located at 9290 Gaither Rd in Gaithersburg. It employs 11 employees and is generating approximately $710,000.00 in annual revenue. Additional โ€ฆSee details»

BioAvenge organization à vendre Montréal | LesPAC

BioAvenge organization à vendre à Montréal. Trouvez tout ce dont vous avez de besoin directement sur LesPAC! Que vous souhaitiez vendre ou acheter quelque chose par rapport โ€ฆSee details»

Avenge Bio Announces Closing of $45 Million Series A Financing

NATICK, Mass., Jan. 5, 2022 /PRNewswire/ -- Avenge Bio, Inc., a biotechnology company developing the LOCOcyteโ„ข immunotherapy platform for the precision administration of potent โ€ฆSee details»

Avenge Bio Receives FDA Orphan Drug Designation for AVB-001 โ€ฆ

Jun 15, 2023 NATICK, Mass. and QUINCY, Mass., June 15, 2023 /PRNewswire/ -- Avenge Bio, Inc. ("Avenge"), a clinical stage, oncology-focused biotechnology company developing the โ€ฆSee details»

Bioavenge+organization | New & Used Personal Care Items for โ€ฆ

Find Bioavenge+organization in Personal Care | Find new & used personal care items for sale. View all personal care items for sale near you including hair dryers, curling irons & โ€ฆSee details»

BioAvenge+organization - NL Classifieds

Find Bioavenge+organization in BBQs, Grills & Outdoor Cooking | Find new & used BBQs, grills & other outdoor cooking items for sale. Shop the largest local selection of new and used BBQs, โ€ฆSee details»

AvengeBio - Crunchbase Company Profile & Funding

AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors. It is a developer of a drug delivery platform intended to treat cancer.See details»

15 Biggest NGOs in Canada - Human Rights Careers

Globally, the NGO reached 13 million people in 2022. That same year, Canadaโ€™s branch reached over 17,000 people through its programs that focus on emergency relief, transformational โ€ฆSee details»

Ravel Biotechnology - Crunchbase

Organization. Ravel Biotechnology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. ... BioAvenge โ€ฆSee details»

AvengeBio - Funding, Financials, Valuation & Investors - Crunchbase

AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors.See details»